Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 2/10

vs
industry
vs
history
Cash-to-Debt 0.01
AMRS's Cash-to-Debt is ranked lower than
99% of the 1089 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.69 vs. AMRS: 0.01 )
Ranked among companies with meaningful Cash-to-Debt only.
AMRS' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01  Med: 0.65 Max: N/A
Current: 0.01
Equity-to-Asset -1.63
AMRS's Equity-to-Asset is ranked lower than
99% of the 1057 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.55 vs. AMRS: -1.63 )
Ranked among companies with meaningful Equity-to-Asset only.
AMRS' s Equity-to-Asset Range Over the Past 10 Years
Min: -1.63  Med: -0.23 Max: 0.87
Current: -1.63
-1.63
0.87
Piotroski F-Score: 3
Altman Z-Score: -17.53
Beneish M-Score: -6.49
WACC vs ROIC
19.69%
-2157.15%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating Margin % -227.34
AMRS's Operating Margin % is ranked lower than
97% of the 1070 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 6.87 vs. AMRS: -227.34 )
Ranked among companies with meaningful Operating Margin % only.
AMRS' s Operating Margin % Range Over the Past 10 Years
Min: -434.9  Med: -252.28 Max: -98.14
Current: -227.34
-434.9
-98.14
Net Margin % -165.14
AMRS's Net Margin % is ranked lower than
97% of the 1073 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 4.79 vs. AMRS: -165.14 )
Ranked among companies with meaningful Net Margin % only.
AMRS' s Net Margin % Range Over the Past 10 Years
Min: -638.16  Med: -200.03 Max: 5.28
Current: -165.14
-638.16
5.28
ROA % -81.88
AMRS's ROA % is ranked lower than
98% of the 1096 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 4.19 vs. AMRS: -81.88 )
Ranked among companies with meaningful ROA % only.
AMRS' s ROA % Range Over the Past 10 Years
Min: -133.56  Med: -55.57 Max: 1.1
Current: -81.88
-133.56
1.1
ROC (Joel Greenblatt) % -81.51
AMRS's ROC (Joel Greenblatt) % is ranked lower than
96% of the 1089 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 12.95 vs. AMRS: -81.51 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
AMRS' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -193.95  Med: -146.73 Max: 25.82
Current: -81.51
-193.95
25.82
3-Year Revenue Growth Rate -40.80
AMRS's 3-Year Revenue Growth Rate is ranked lower than
97% of the 940 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.60 vs. AMRS: -40.80 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
AMRS' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0  Med: -53.5 Max: -40.8
Current: -40.8
3-Year EBITDA Growth Rate -33.60
AMRS's 3-Year EBITDA Growth Rate is ranked lower than
95% of the 839 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 7.40 vs. AMRS: -33.60 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
AMRS' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: -34.5 Max: -17.7
Current: -33.6
3-Year EPS without NRI Growth Rate -21.50
AMRS's 3-Year EPS without NRI Growth Rate is ranked lower than
87% of the 750 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 8.00 vs. AMRS: -21.50 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
AMRS' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: -35.6 Max: -21.5
Current: -21.5
GuruFocus has detected 5 Warning Signs with Amyris Inc $AMRS.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» AMRS's 10-Y Financials

Financials (Next Earnings Date: 2017-03-02)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with AMRS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Chemicals » Specialty Chemicals    NAICS: 325199    SIC: 2899
Compare:NAS:TVIA, NAS:GURE, NAS:SYMX, NAS:NTIC, OTCPK:LPAD, OTCPK:CXUSF, NAS:SNMX, OTCPK:LWLG, OTCPK:APGMF, OTCPK:HDGHF, OTCPK:DTRX, OTCPK:NNOMF, NYSE:ODC, NAS:TORM, NAS:AMTX, OTCPK:NANX, NAS:IKNX, AMEX:FSI, OTCPK:ADMT, NAS:DELT » details
Traded in other countries:3A0.Germany,
Amyris Inc is a renewable products company engaged in providing sustainable alternatives to petroleum-sourced products. It developed microbial engineering and screening technologies that modify the way microorganisms process sugars.

Amyris Inc was incorporated in California on July 17, 2003 and reincorporated in Delaware on June 10, 2010. The Company is a renewable products company engaged in providing sustainable alternatives to petroleum-sourced products. It developed microbial engineering and screening technologies that modify the way microorganisms process sugars. The Company is engaged in developing various products to address five identified markets including cosmetics, lubricants, flavors and fragrances, performance materials, and transportation fuels. The Company is using its proprietary synthetic biology platform to design microbes, mainly yeast, and use them as living factories in established fermentation processes to convert plant-sourced sugars into renewable hydrocarbons. The Company is developing, and, in some cases, already commercializing, products from these hydrocarbons in several target markets, including cosmetics, lubricants, flavors and fragrances, performance materials, and transportation fuels. It calls these No Compromise products because it designs them to perform comparably to currently available products. The Company's first commercialization efforts have been focused on a renewable hydrocarbon molecule called farnesene Biofene, which forms the basis for various products varying from specialty chemical applications to transportation fuels, such as diesel. In addition, the Company has entered into various contract manufacturing agreements to support commercial production. The Company had 413 issued U.S. and foreign patents and 295 pending U.S. and foreign patent applications that are owned by or licensed to it. The Company is subject to a various federal, state, local and international laws, regulations and permit requirements governing the use, generation, manufacture, transportation, storage, handling and disposal of these materials in the United States, Brazil and other countries where it operates.

Ratios

vs
industry
vs
history
PS Ratio 2.07
AMRS's PS Ratio is ranked lower than
67% of the 1103 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.34 vs. AMRS: 2.07 )
Ranked among companies with meaningful PS Ratio only.
AMRS' s PS Ratio Range Over the Past 10 Years
Min: 0.52  Med: 3.52 Max: 9.58
Current: 2.07
0.52
9.58
Current Ratio 0.16
AMRS's Current Ratio is ranked lower than
99% of the 1016 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.81 vs. AMRS: 0.16 )
Ranked among companies with meaningful Current Ratio only.
AMRS' s Current Ratio Range Over the Past 10 Years
Min: 0.16  Med: 1.38 Max: 11.36
Current: 0.16
0.16
11.36
Quick Ratio 0.10
AMRS's Quick Ratio is ranked lower than
99% of the 1016 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.32 vs. AMRS: 0.10 )
Ranked among companies with meaningful Quick Ratio only.
AMRS' s Quick Ratio Range Over the Past 10 Years
Min: 0.09  Med: 1.24 Max: 11.22
Current: 0.1
0.09
11.22
Days Inventory 76.56
AMRS's Days Inventory is ranked lower than
60% of the 1035 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 64.38 vs. AMRS: 76.56 )
Ranked among companies with meaningful Days Inventory only.
AMRS' s Days Inventory Range Over the Past 10 Years
Min: 11.23  Med: 42.83 Max: 139.58
Current: 76.56
11.23
139.58
Days Sales Outstanding 38.01
AMRS's Days Sales Outstanding is ranked higher than
79% of the 864 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 59.33 vs. AMRS: 38.01 )
Ranked among companies with meaningful Days Sales Outstanding only.
AMRS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 7.75  Med: 22.19 Max: 73.27
Current: 38.01
7.75
73.27
Days Payable 110.93
AMRS's Days Payable is ranked higher than
86% of the 818 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 49.21 vs. AMRS: 110.93 )
Ranked among companies with meaningful Days Payable only.
AMRS' s Days Payable Range Over the Past 10 Years
Min: 10.32  Med: 62.01 Max: 110.93
Current: 110.93
10.32
110.93

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -44.20
AMRS's 3-Year Average Share Buyback Ratio is ranked lower than
96% of the 469 Companies
in the Global Specialty Chemicals industry.

( Industry Median: -1.60 vs. AMRS: -44.20 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
AMRS' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -143.6  Med: -20.5 Max: 0
Current: -44.2
-143.6
0

Valuation & Return

vs
industry
vs
history
Price-to-Median-PS-Value 0.59
AMRS's Price-to-Median-PS-Value is ranked higher than
94% of the 1011 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.34 vs. AMRS: 0.59 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
AMRS' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.36  Med: 1.13 Max: 2.76
Current: 0.59
0.36
2.76
Earnings Yield (Greenblatt) % -17.32
AMRS's Earnings Yield (Greenblatt) % is ranked lower than
95% of the 1147 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.20 vs. AMRS: -17.32 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
AMRS' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -17.47  Med: 7.7 Max: 8.7
Current: -17.32
-17.47
8.7

More Statistics

Revenue (TTM) (Mil) $54.80
EPS (TTM) $ -0.30
Beta-1.06
Short Percentage of Float10.25%
52-Week Range $0.31 - 1.62
Shares Outstanding (Mil)263.02

Analyst Estimate

Dec16 Dec17
Revenue (Mil $) 84 166
EPS ($) -0.32 -0.15
EPS without NRI ($) -0.32 -0.15
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for AMRS

Headlines

Articles On GuruFocus.com
Weekly CEO Sells Highlights Jun 21 2016 
Insiders Top Buys: Amyris Inc. Aug 07 2015 
Weekly CEO Sells Highlight: Netlist Inc, LifePoint Hospitals Inc, Amyris Inc, and Sapient Corp. May 25 2014 
Billionaires Hold Waning Biotechs 42% Off Oct 16 2013 
Weekly CEO Sells Highlight: Amyris, AtriCure, 3D Systems Corporation and Cooper Tire & Rubber Compan Sep 10 2012 
Weekly CFO Sells Highlight: SCHW, TIBX, IL, AMRS, BCR, CCOI, CBST Apr 24 2011 
Weekly CEO Sells Highlight: MU, CRIS, HIL, and AMRS Apr 03 2011 

More From Other Websites
Biotech Meets Beauty as Biossance™ Announces a New Look and Product Launches Feb 21 2017
Gevo's Valentine's Day Massacre Feb 17 2017
Amyris Provides Business Update Feb 03 2017
Amyris to Announce Fourth Quarter and Fiscal Year 2016 Financial Results on Thursday, March 2, 2017 Jan 31 2017
JBS S.A. Announces Independent Members of the Board of Its Subsidiary JBS Foods International Jan 30 2017
AMYRIS, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement, Creation of a... Jan 18 2017
AMYRIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement Jan 13 2017
AMYRIS, INC. Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an... Jan 06 2017
AMYRIS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Jan 05 2017
Amyris Appoints Kathleen Valiasek as Chief Financial Officer Jan 05 2017
Amyris Appoints Kathleen Valiasek as Chief Financial Officer Jan 05 2017
Amyris Agrees Debt Exchange to Extend Maturities to 2019 Dec 29 2016
AMYRIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct... Dec 29 2016
Amyris Agrees Debt Exchange to Extend Maturities to 2019 Dec 29 2016
AMYRIS, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Creation of a... Dec 23 2016
Is the Options Market Predicting a Spike in Amyris (AMRS) Stock? Dec 23 2016
AMYRIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of... Dec 16 2016
ETFs with exposure to Amyris, Inc. : December 14, 2016 Dec 14 2016
Chevron Makes Equity Investment in Novvi and its High-Performance Renewable Base Oil Technology Dec 14 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)